Xiaojing Zeng

Title: The Innovative Contributions of Xiaojing Zeng in Nanobody Screening Technologies

Introduction: Xiaojing Zeng, an accomplished inventor based in Shenzhen, China, has made significant strides in the field of biotechnology. With a focus on advancing the methodology for screening nanobodies, Zeng's innovative approach is set to impact various applications in medical and research settings.

Latest Patents: Xiaojing Zeng holds one patent titled "Method and system for screening nanobody." This patent details a pioneering method that employs polymerase chain reactions alongside cDNA 5' end rapid amplification technology. This innovative technique facilitates efficient screening and acquisition of nanobodies, with an impressive experiment cycle time of approximately 21 days.

Career Highlights: Zeng is currently affiliated with BGI Shenzhen, a prominent biotechnology company renowned for its contributions to genomics and personalized medicine. His work within this dynamic environment leverages cutting-edge technology to push the boundaries of current biotechnological methods.

Collaborations: Throughout his career, Xiaojing Zeng has collaborated with notable colleagues, including Xiao Liu and Chao Nie. These partnerships have fostered a collaborative approach to research and development, enhancing the potential for innovation in screening technologies.

Conclusion: In summary, Xiaojing Zeng represents a remarkable figure in modern biotechnology. His contributions to the methods of screening nanobodies exemplify the power of innovation and collaboration in advancing scientific knowledge and applications. As BGI Shenzhen continues to thrive, Zeng's work will undoubtedly have a lasting impact on the field.